tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
Company AnnouncementsNurExone Biologic Reports Q2 2025 Financial Results and Strategic Advancements
3d ago
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
PremiumCompany Announcements
NurExone Biologic Reveals Promising Preclinical Results and Closes C$0.78 Million Funding
11d ago
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
PremiumCompany Announcements
NurExone’s Exosomes Outperform Industry Standards in Healing Potential
23d ago
NurExone Biologic Finalist in Falling Walls Venture 2025
PremiumCompany Announcements
NurExone Biologic Finalist in Falling Walls Venture 2025
1M ago
NurExone’s ExoPTEN Shows Promising Preclinical Results in Spinal Cord Injury Model
PremiumCompany Announcements
NurExone’s ExoPTEN Shows Promising Preclinical Results in Spinal Cord Injury Model
2M ago
NurExone Expands U.S. Presence with HealthTech Hub Entry and Omnibus Plan Approval
PremiumCompany AnnouncementsNurExone Expands U.S. Presence with HealthTech Hub Entry and Omnibus Plan Approval
2M ago
NurExone Advances ExoPTEN Manufacturing and Seeks Shareholder Approval for Omnibus Plan
Premium
Company Announcements
NurExone Advances ExoPTEN Manufacturing and Seeks Shareholder Approval for Omnibus Plan
3M ago
NurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026
Premium
Company Announcements
NurExone Biologic to Launch Clinical Trials for ExoPTEN in 2026
3M ago
NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements
PremiumCompany Announcements
NurExone Biologic Reports Q1 2025 Financials and Strategic Advancements
3M ago
NurExone Biologic Unveils Promising Preclinical Data on Optic Nerve Regeneration at ARVO 2025
PremiumCompany Announcements
NurExone Biologic Unveils Promising Preclinical Data on Optic Nerve Regeneration at ARVO 2025
4M ago
NurExone Biologic Expands European Engagement with Key Investor Events
PremiumCompany Announcements
NurExone Biologic Expands European Engagement with Key Investor Events
4M ago
NurExone Unveils Breakthrough in Facial Nerve Regeneration at ISEV 2025
PremiumCompany Announcements
NurExone Unveils Breakthrough in Facial Nerve Regeneration at ISEV 2025
4M ago
NurExone Expands U.S. Operations with New Leadership and Ontario Continuance
PremiumCompany AnnouncementsNurExone Expands U.S. Operations with New Leadership and Ontario Continuance
4M ago
NurExone Biologic Secures C$2.3 Million Funding for U.S. Expansion and Uplisting Plans
Premium
Company Announcements
NurExone Biologic Secures C$2.3 Million Funding for U.S. Expansion and Uplisting Plans
5M ago
EnerSpar Corp. (NRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
EnerSpar Corp. (NRX) Q4 Earnings Cheat Sheet
5M ago
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
PremiumCompany Announcements
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
6M ago
NurExone Biologic to Showcase Ophthalmology Innovations at MIXiii 2025
PremiumCompany Announcements
NurExone Biologic to Showcase Ophthalmology Innovations at MIXiii 2025
6M ago
NurExone Biologic Earns Spot on 2025 TSX Venture 50™
PremiumCompany Announcements
NurExone Biologic Earns Spot on 2025 TSX Venture 50™
6M ago
NurExone Biologic Expands U.S. Market Presence with Key Conference Presentation
PremiumCompany Announcements
NurExone Biologic Expands U.S. Market Presence with Key Conference Presentation
7M ago
NurExone Biologic Expands with New U.S. Subsidiary for Exosome Commercialization
PremiumCompany AnnouncementsNurExone Biologic Expands with New U.S. Subsidiary for Exosome Commercialization
7M ago
NurExone Biologic Raises Over C$1.2 Million and Appoints New R&D Director
Premium
Company Announcements
NurExone Biologic Raises Over C$1.2 Million and Appoints New R&D Director
7M ago
NurExone Biologic Advances Exosome Therapy with Key Acquisition
Premium
Company Announcements
NurExone Biologic Advances Exosome Therapy with Key Acquisition
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >